Search results for: 'microbiology AND diagnostic'

31 Jul 2023  |  North America  |  Market Research

Global Oncology Diagnostics in IVD Growth Opportunities

By Leveraging Data-driven Solutions, Co-development Opportunities, and Assay Innovation, Clients Can Experience Enhanced Product Performance, Cost-effectiveness, and Improved Decision-making Capabilities

Infographics

×

The global oncology diagnostics in IVD market is expected to witness significant growth, driven by an increase in cancer incidence, technological developments in diagnostic tests, the growing number of screening tests, and supportive government initiatives. Owing to the intense competition in the market, the most prominent companies are investing h...

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...

This research service analyzes the market for rapid microbiology tests within the United States. The market was divided into the three segments. Each segment covers market trends, technology trends, competitive structure, market share analysis and revenue forecasts. The key challenges and strategies are covered for the total market overview.

The U.S. Rapid Microbiology Test Market report focuses on the changing platforms employed in clinical as well as non-clinical environments. This report covers the strep, STD, respiratory, gastrointestinal, and non-clinical applications. This report provides an in-depth analysis of the revenue and unit sales forecasts for the market, drivers and res...

Computed tomography (CT) is a sophisticated imaging technology that combines X-ray measurements obtained from multiple angles and processes them using computer algorithms to generate cross-sectional images or tomograms. The tomograms are further reconstructed into a 3D representation of organs or tissues, allowing precise visualization of the inter...

23 May 2017  |  North America  |  Market Research

Growth Opportunities in the US In Vitro Diagnostics (IVD) Market, Forecast to 2021

US IVD Market Witnesses Pricing Fluctuations Due to the PAMA Regulation

Infographics

×

The In Vitro Diagnostics (IVD) landscape in the United States is extremely dynamic, with a high level of merger and acquisition activity with many high-value deals still pending. Both clinical laboratories and manufacturers are increasingly vying for smaller specialized niche technology companies to increase their market share. Molecular point of c...

This study addresses the current shift from in-hospital settings to non-hospital or outpatient settings for medical imaging service providers in the US and EU. The focus is on X-ray, ultrasound, mammography, MRI, and imaging IT solutions delivered in outpatient settings, such as ambulatory surgery centers (ASCs), independent imaging diagnostic cent...

06 Mar 2020  |  North America  |  Market Research

Demand Analysis for Handheld Diagnostic Tools in North America, Forecast to 2026

Vehicle Complexity Driving Migration to More Advanced Diagnostics Devices

Infographics

×

Key Issues Addressed

The proliferation of new car features, including advanced driver assistance systems, telematics/infotainment modules, and alternative powertrains, requires automotive repair shops to continually invest in new handheld diagnostic tools that can read the latest vehicle fault codes. Without up-to-date tools, service providers in the automotive afterma...

14 Mar 2022  |  North America  |  Market Outlook

Next-generation Diagnostics Outlook, 2022

Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

Infographics

×

In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...